Olvido, Danna Jane D.
HRN: 22-50-58 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/24/2023
DOXYCYCLINE 100MG (CAP)
01/24/2023
01/31/2023
PO
100
Bid
S/p EL Salpingoophorectomy
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes